Pharmaids [PHARMAID] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Pharmaids

BSE
Loading...

Divi's Laboratories

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pharmaids wins in 5 metrics, Divi's Laboratories wins in 13 metrics, with 0 ties. Divi's Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricPharmaidsDivi's LaboratoriesBetter
P/E Ratio (TTM)2,023.3370.61Divi's Laboratories
Price-to-Book Ratio3.3510.85Pharmaids
Debt-to-Equity Ratio70.810.03Divi's Laboratories
PEG Ratio23.662.67Divi's Laboratories
EV/EBITDA-16.2251.72Pharmaids
Profit Margin (TTM)-61.01%23.89%Divi's Laboratories
Operating Margin (TTM)-90.28%25.60%Divi's Laboratories
EBITDA Margin (TTM)N/A25.60%N/A
Return on Equity-19.58%14.64%Divi's Laboratories
Return on Assets (TTM)-8.99%12.94%Divi's Laboratories
Free Cash Flow (TTM)$-264.72M$2.15BDivi's Laboratories
Dividend YieldN/A0.91%N/A
1-Year Return30.67%-0.61%Pharmaids
Price-to-Sales Ratio (TTM)9.2516.83Pharmaids
Enterprise Value$2.35B$1,585.32BDivi's Laboratories
EV/Revenue Ratio10.9816.43Pharmaids
Gross Profit Margin (TTM)47.39%60.33%Divi's Laboratories
Revenue per Share (TTM)$6$363Divi's Laboratories
Earnings per Share (Diluted)$-3.71$86.68Divi's Laboratories
Beta (Stock Volatility)0.530.18Divi's Laboratories
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Pharmaids vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Pharmaids
Divi's Laboratories
Pharmaids Stock Overview | Divi's Laboratories Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pharmaids-5.46%-12.16%-14.88%-8.85%-19.65%-29.42%
Divi's Laboratories0.26%7.29%1.28%-11.38%16.08%0.52%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pharmaids30.67%281.24%550.44%1,134.75%1,482.73%125.13%
Divi's Laboratories-0.61%70.86%89.42%470.70%1,608.03%8,411.57%

News Based Sentiment: Pharmaids vs Divi's Laboratories

Pharmaids

News based Sentiment: MIXED

September brought substantial changes to Pharmaids Pharmaceuticals, including a major divestiture and an ongoing open offer, alongside continued financial difficulties. These events create both opportunities and risks for investors, making it a significant month for the company's trajectory. The mixed signals from insider trading add to the complexity of the investment picture.

View Pharmaids News Sentiment Analysis

Divi's Laboratories

News based Sentiment: MIXED

Divi's Laboratories reported strong quarterly results and is strategically diversifying its revenue base, but faces operational challenges and mixed analyst sentiment. The technical indicators also present a cautious outlook, creating a complex investment narrative with both opportunities and risks.

View Divi's Laboratories News Sentiment Analysis

Performance & Financial Health Analysis: Pharmaids vs Divi's Laboratories

MetricPHARMAIDDIVISLAB
Market Information
Market Cap i₹1.98B₹1.68T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i4,989535,714
90 Day Avg. Volume i4,937409,930
Last Close₹49.38₹6,120.50
52 Week Range₹45.50 - ₹84.97₹4,955.00 - ₹7,071.50
% from 52W High-41.89%-13.45%
All-Time High₹87.46 (Nov 11, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-43.54%-13.45%
Growth Metrics
Quarterly Revenue Growth0.43%0.14%
Quarterly Earnings Growth0.43%0.27%
Financial Health
Profit Margin (TTM) i-0.61%0.24%
Operating Margin (TTM) i-0.90%0.26%
Return on Equity (TTM) i-0.20%0.15%
Debt to Equity (MRQ) i70.810.03
Cash & Liquidity
Book Value per Share (MRQ)₹16.72₹563.87
Cash per Share (MRQ)₹0.61₹132.86
Operating Cash Flow (TTM) i₹-278,094,000₹19.67B
Levered Free Cash Flow (TTM) i₹-107,766,000₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Pharmaids vs Divi's Laboratories

MetricPHARMAIDDIVISLAB
Price Ratios
P/E Ratio (TTM) i2,023.3370.61
Forward P/E iN/A108.71
PEG Ratio i23.662.67
Price to Sales (TTM) i9.2516.83
Price to Book (MRQ) i3.3510.85
Market Capitalization
Market Capitalization i₹1.98B₹1.68T
Enterprise Value i₹2.35B₹1.59T
Enterprise Value Metrics
Enterprise to Revenue i10.9816.43
Enterprise to EBITDA i-16.2251.72
Risk & Other Metrics
Beta i0.530.18
Book Value per Share (MRQ) i₹16.72₹563.87

Financial Statements Comparison: Pharmaids vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PHARMAIDDIVISLAB
Revenue/Sales i₹66.64M₹24.10B
Cost of Goods Sold i₹35.06M₹9.56B
Gross Profit i₹31.58M₹14.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹-60.16M₹6.17B
EBITDA i₹-53.69M₹8.48B
Pre-Tax Income i₹-71.71M₹7.33B
Income Tax i₹-18.56M₹1.88B
Net Income (Profit) i₹-53.15M₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PHARMAIDDIVISLAB
Cash & Equivalents i₹21.45M₹4.15B
Total Current Assets i₹223.07M₹100.81B
Total Current Liabilities i₹287.15M₹14.52B
Long-Term Debt i₹331.19M₹20.00M
Total Shareholders Equity i₹550.42M₹149.69B
Retained Earnings i₹-266.77M₹134.00B
Property, Plant & Equipment i₹19.32M₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PHARMAIDDIVISLAB
Operating Cash Flow i₹-1.10MN/A
Capital Expenditures i₹0N/A
Free Cash Flow i₹2.39MN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPHARMAIDDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i4,989535,714
Average Daily Volume (90 Day) i4,937409,930
Shares Outstanding i35.27M265.47M
Float Shares i5.78M120.77M
% Held by Insiders i0.77%0.52%
% Held by Institutions i0.00%0.29%

Dividend Analysis & Yield Comparison: Pharmaids vs Divi's Laboratories

MetricPHARMAIDDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025